IMRX
Immuneering Corp. Class A · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website immuneering.com
- Employees(FY) 67
- ISIN US45254E1073
Performance
-6.84%
1W
+2.88%
1M
-43.92%
3M
-79.57%
6M
-80.54%
YTD
-84.9%
1Y
Profile
Immuneering Corporation, a clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor currently under Phase 1/2a clinical trial to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 currently in Investigational New Drug application to treat solid tumors. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts.
Technical Analysis of IMRX 2024-05-31
Overview:
In analyzing the technical indicators for IMRX over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive assessment of the stock's potential price movement. By examining these key factors, we aim to offer valuable insights and predictions for the upcoming days.
Trend Anal...
Recent News & Updates
- 2023-05-29 20:00
- 2023-05-04 07:25
- 2023-05-04 04:05
- 2023-04-17 21:24
Immuneering Announces $30 Million Underwritten Offering(Yahoo Finance)
- 2023-04-17 21:00
- 2023-04-17 16:20
- 2023-04-12 04:05
- 2023-04-10 15:56
- 2023-04-04 20:00
- 2023-03-27 20:00
- 2023-03-26 21:55
- 2023-03-24 01:25
Why Shares of Immuneering Jumped This Week(Yahoo Finance)
- 2023-03-22 18:18
- 2023-03-14 04:30
- 2023-03-08 20:55
- 2023-03-07 18:14
- 2023-03-06 04:45
- 2023-03-06 03:05
- 2023-03-05 05:30
- 2023-02-27 19:00
- 2023-02-26 19:00
- 2023-02-04 18:18
- 2023-01-30 17:50
- 2022-11-27 17:50
- 2022-11-15 17:35
Immuneering Third Quarter 2022 Earnings: Revenues Disappoint(Yahoo Finance)
- 2022-11-09 21:15
- 2022-11-09 20:00
- 2022-11-09 20:00
- 2022-11-02 18:50
- 2022-10-19 18:50
Immuneering Appoints Leah R. Neufeld as Chief People Officer(Yahoo Finance)